Chronic complications of diabetes mellitus in newly diagnosed patients

International Journal of Diabetes Mellitus

Volumn 2, Issue 1, 2010, Pages 61-63

  Heydari, Iraj ^a   Radi, Vida ^a   Razmjou, Sara ^a   Amiri, Afsaneh ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Nephropathy; Neuropathy; Retinopathy

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; HUMAN; HYPERLIPIDEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; SCREENING TEST;

EID: 77749310087     PISSN: 18775934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdm.2009.08.001     Document Type: Article

References (21)

1. Hovens MMC, Van de Laar FA, Cannegieter SC, Vandenbroucke JP. Acetylsalicylic acid (Aspirin) for primary prevention of cardiovascular disease in type 2 Diabetes Mellitus (protocol). Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005446.
2. Arinzon Z., Shabat S., Shuval I., Peisakh A., and Berner Y. Prevalence of Diabetes Mellitus in elderly patients received enteral nutrition long-term care service. Arch Gerontol Geriatr. (2007)
3. Bethel M.A., Sloan F.A., Belsky D., and Feinglos M.N. Longitudinal incidence and prevalence of adverse outcomes of Diabetes Mellitus in elderly patients. Arch Intern Med. 167 9 (2007) 921-927
4. Piechowski-Jozwiak B., Maulaz A., and Bogousslavsky J. Secondary prevention of stroke with antiplatelet agents in patients with Diabetes Mellitus. Cerebrovasc Dis. 20 Suppl 1 (2005) 15-23
5. Spijkerman A.M., Dekker J.M., Nijpels G., Adriaanse M.C., Kostense P.J., Ruwaard D., et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care. 26 9 (2003) 2604-2608
6. Krentz A.J., Clough G., and Byrne C.D. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 9 6 (2007) 781-791
7. Rosolova H., Petrlova B., Simon J., Sifalda P., Sipova I., and Sefrna F. Macrovascular and microvascular complications in type 2 diabetes patients. Vnitr Lek. 54 3 (2008) 229-237
8. Scheffel R.S., Bortolanza D., Weber C.S., Costa L.A., Canani L.H., Santos K.G., et al. Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus. Rev Assoc Med Bras. 50 3 (2004) 263-267
9. Bleyer A.J., Sedor J.R., Freedman B.I., O'Brien A., Russell G.B., Graley J., et al. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. Am J Kidney Dis. 51 1 (2008) 29-37
10. Dyck P.J. Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 11 (1988) 21-32
11. Rahman S., Rahman T., Ismail A.A., and Rashid A.R. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 9 6 (2007) 767-780
12. Adeghate E., Schattner P., and Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 1084 (2006) 1-29
13. Azimi-Nezhad M., Ghayour-Mobarhan M., Parizadeh M.R., Safarian M., Esmaeili H., Parizadeh S.M., et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 49 7 (2008) 571-576
14. 14. Somaratne JB, Whalley GA, Bagg W, Doughty RN. Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 Diabetes Mellitus. Expert Rev Cardiovasc Ther. 6 1 (2008) 109-125
15. Harzallah F., Ncibi N., Alberti H., Ben Brahim A., Smadhi H., Kanoun F., et al. Clinical and metabolic characteristics of newly diagnosed diabetes patients: experience of a university hospital in Tunis. Diabetes Metab. 32 6 (2006) 632-635
16. Weerasuriya N., Siribaddana S., Dissanayake A., Subasinghe Z., Wariyapola D., and Fernando D.J. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. QJM 91 6 (1998) 439-443
17. Osterby R., Gall M.A., Schmitz A., Nielsen F.S., Nyberg G., and Parving H.H. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36 10 (1993) 1064-1070
18. Matthews D.R., Stratton I.M., Aldington S.J., Holman R.R., and Kohner E.M. UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 Diabetes Mellitus: UKPDS 69. Arch Ophthalmol. 122 11 (2004) 1631-1640
19. Funatsu H., and Yamashita H. Pathogenesis of diabetic retinopathy and the renin-angiotensin system. Ophthalmic Physiol Opt. 23 6 (2003) 495-501
20. Zander E., Heinke P., Herfurth S., Reindel J., Ostermann F.E., and Kerner W. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients. Exp Clin Endocrinol Diabetes 105 6 (1997) 319-322
21. Sprafka J.M., Bender A.P., and Jagger H.G. Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study. Diabetes Care. 11 1 (1988) 17-22